TB

The purpose of this document is to highlight cases in which Advocacy, Communication and Social Mobilization (ACSM) interventions have contributed to a positive outcome of tuberculosis (TB) control activities directed to a range of audiences and settings. It is intended for on-the-ground stakeholders who are interested in successfully integrating ACSM strategies and activities into TB control programming, as well as for decision-makers who can provide greater political and financial support for ACSM activities at the national, sub-national and international level.

This advocacy brochure shows how one million lives can be saved by the end of 2015 by preventing and treating tuberculosis among people living with HIV.

The 2013 World TB Day campaign will allow people all over the world to make an individual call to stop TB in their lifetimes.

On this website, you will find a media centre, blog, and resources. These resources include campaign documents, posters, and t-shirt designs. The resources come in six languages - Arabic, Chinese, English, French, Russian, and Spanish.

This Course is intended as an introduction to multidrug-resistant tuberculosis (MDR-TB) management, and is aimed at medical practitioners involved in the detection, management and treatment of MDR-TB patients, under the guiding principles of the World Health Organization's Stop TB Strategy. The Course aims to facilitate self-study by medical practitioners of contemporary, evidence-based standards for diagnosis and clinical management of MDR-TB in a variety of geographical, economic and social settings.

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. For each of the three CDC-recommended LTBI regimens, there is a fact sheet in the series that can be personalized for individual patients. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This tool is designed to support the effective monitoring and evaluation (M&E) of tuberculosis (TB) control programs in refugee camps and other settings located in resource-poor areas.

This video provides information on MDR-TB.

This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and ?nancing TB prevention, care and control at global, regional and country levels using data reported by 197 countries and territories that account for over 99% of the world’s TB cases.

This timeline shows TB innovations throughout history.

This laboratory manual references best practices from the Clinical and Laboratory Standards Institute (CLSI), the Foundation for Innovative New Diagnostics (FIND) MGIT Procedure Manual, and laboratory procedures from the National Institutes of Health TB Research Unit, as well as biosafety recommendations from the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC).

Information in the manual includes standardized procedures related to sputum collection, handling, analyses, and reporting.